This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 Sep 23;321(7263):763-4; author reply 764-5.

Screening for Down's syndrome. Serum screening programmes are effective and safe

N J Wald, A K Hackshaw, W Huttly

PMID: 10999927

Comment

Screening for Down's syndrome. Serum screening programmes are effective and safe

N J Wald et al. BMJ. 2000.

. 2000 Sep 23;321(7263):763-4; author reply 764-5.

Authors

N J Wald, A K Hackshaw, W Huttly

PMID: 10999927

No abstract available

PubMed Disclaimer

Comment on

Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans.
Howe DT, Gornall R, Wellesley D, Boyle T, Barber J. Howe DT, et al. BMJ. 2000 Mar 4;320(7235):606-10. doi: 10.1136/bmj.320.7235.606. BMJ. 2000. PMID: 10698877 Free PMC article.

Similar articles

Screening for Down's syndrome. Biochemical screening offers advantages.
Boyd PA, Jefferies M, Chamberlain PF, Crocker AJ. Boyd PA, et al. BMJ. 2000 Sep 23;321(7263):762; author reply 764-5. BMJ. 2000. PMID: 10999923 Free PMC article. No abstract available.
Screening for Down's syndrome. Serum screening shows a clear benefit across age groups.
McCune GS, Stock AS, Foakes A. McCune GS, et al. BMJ. 2000 Sep 23;321(7263):762-3; author reply 764-5. BMJ. 2000. PMID: 10999924 No abstract available.
Antenatal screening policies for Down's syndrome. Serum screening for Down's syndrome is better than age screening.
Christiansen M, Larsen SO, Nørgaard-Pedersen B. Christiansen M, et al. BMJ. 2002 Nov 2;325(7371):1034; author reply 1034. BMJ. 2002. PMID: 12420332 No abstract available.
[Prenatal diagnosis of Down's syndrome: prediction from maternal serum markers].
Zilberstein T, Maymon E. Zilberstein T, et al. Harefuah. 1998 Mar 1;134(5):393-6. Harefuah. 1998. PMID: 10909560 Review. Hebrew. No abstract available.
Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
Saller DN Jr, Canick JA. Saller DN Jr, et al. Clin Obstet Gynecol. 2008 Mar;51(1):24-36. doi: 10.1097/GRF.0b013e318160f274. Clin Obstet Gynecol. 2008. PMID: 18303497 Review.

See all similar articles

Cited by

The effects of dydrogesterone treatment on first-trimester aneuploidy screening markers and nuchal translucency in women with threatened miscarriage.
Yıldız E, Timur B. Yıldız E, et al. Turk J Obstet Gynecol. 2023 Mar 10;20(1):16-21. doi: 10.4274/tjod.galenos.2023.97493. Turk J Obstet Gynecol. 2023. PMID: 36908009 Free PMC article.
Antenatal screening policies for Down's syndrome. Audit of Down's syndrome screening is not valid.
Wald NJ, Huttly W, Hackshaw AK. Wald NJ, et al. BMJ. 2002 Nov 2;325(7371):1034; author reply 1034. BMJ. 2002. PMID: 12411371 Free PMC article. No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information